Latest news
Braveheart Bio’s $382M IPO for Heart Drug Leads a Big Week for Biotech IPOs - MedCity NewsMedCity News · Mon, 10 Aug 2026 03:12:34 GMTAttovia’s Upsized IPO Brings In $289M to Fund New Kind of Biologic for Immune Disorders - MedCity NewsMedCity News · Wed, 05 Aug 2026 18:46:44 GMTApnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug - MedCity NewsMedCity News · Sun, 02 Aug 2026 22:42:36 GMT